119 related articles for article (PubMed ID: 2584711)
21. Activation of rat complement by soluble and insoluble rat IgA immune complexes.
Rits M; Hiemstra PS; Bazin H; Van Es LA; Vaerman JP; Daha MR
Eur J Immunol; 1988 Dec; 18(12):1873-80. PubMed ID: 3220102
[TBL] [Abstract][Full Text] [Related]
22. Modulation of Fc and C3b receptor activity of mouse peritoneal macrophages elicited by preformed immune complexes.
Tripathi AK; Chakrabarty AK; Sengupta P; Saha K
Indian J Exp Biol; 1994 Mar; 32(3):149-54. PubMed ID: 8070833
[TBL] [Abstract][Full Text] [Related]
23. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
24. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
Pascual M; Schifferli JA
Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
[TBL] [Abstract][Full Text] [Related]
25. Generation of low m.w., C3-bearing immunoglobulin in human serum.
Jacobs RJ; Reichlin M
J Immunol; 1983 Jun; 130(6):2775-81. PubMed ID: 6602181
[TBL] [Abstract][Full Text] [Related]
26. Circulating DNA-anti-DNA complexes in lupus nephritis and idiopathic nephritis.
Williams DG; Adu D
Proc Eur Dial Transplant Assoc; 1980; 17():629-36. PubMed ID: 6787585
[TBL] [Abstract][Full Text] [Related]
27. Effect of H chain V region on complement activation by immobilized immune complexes.
Horgan C; Brown K; Pincus SH
J Immunol; 1992 Jul; 149(1):127-35. PubMed ID: 1607649
[TBL] [Abstract][Full Text] [Related]
28. Abnormal immune adherence and elimination of hepatitis B surface antigen/antibody complexes in patients with AIDS.
Madi N; Steiger G; Estreicher J; Schifferli JA
J Immunol; 1992 Feb; 148(3):723-8. PubMed ID: 1530955
[TBL] [Abstract][Full Text] [Related]
29. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials.
Charles PJ; Smeenk RJ; De Jong J; Feldmann M; Maini RN
Arthritis Rheum; 2000 Nov; 43(11):2383-90. PubMed ID: 11083258
[TBL] [Abstract][Full Text] [Related]
30. Monoclonal antibodies to mouse complement receptor type 1 (CR1). Their use in a distribution study showing that mouse erythrocytes and platelets are CR1-negative.
Kinoshita T; Takeda J; Hong K; Kozono H; Sakai H; Inoue K
J Immunol; 1988 May; 140(9):3066-72. PubMed ID: 2966205
[TBL] [Abstract][Full Text] [Related]
31. Complement fixation by small, DNase-resistant DNA-anti-DNA immune complexes.
Horgan C; Emlen W
Mol Immunol; 1987 Feb; 24(2):109-16. PubMed ID: 3497335
[TBL] [Abstract][Full Text] [Related]
32. Characterization of a soluble form of the C3b/C4b receptor (CR1) in human plasma.
Yoon SH; Fearon DT
J Immunol; 1985 May; 134(5):3332-8. PubMed ID: 3156931
[TBL] [Abstract][Full Text] [Related]
33. Direct evidence for the clustered nature of complement receptors type 1 on the erythrocyte membrane.
Paccaud JP; Carpentier JL; Schifferli JA
J Immunol; 1988 Dec; 141(11):3889-94. PubMed ID: 2972779
[TBL] [Abstract][Full Text] [Related]
34. Complement component C3b and immunoglobulin Fc receptors on neutrophils from calves with leukocyte adhesion deficiency.
Worku M; Paape MJ; Di Carlo A; Kehrli ME; Marquardt WW
Am J Vet Res; 1995 Apr; 56(4):435-9. PubMed ID: 7785817
[TBL] [Abstract][Full Text] [Related]
35. Identification of a C3b/iC3 binding protein of rabbit platelets and leukocytes. A CR1-like candidate for the immune adherence receptor.
Manthei U; Nickells MW; Barnes SH; Ballard LL; Cui WY; Atkinson JP
J Immunol; 1988 Feb; 140(4):1228-35. PubMed ID: 2963863
[TBL] [Abstract][Full Text] [Related]
36. In vivo generation and clearance of soluble immune complexes containing IgM antibodies in normal and decomplemented rabbits.
Brown DL; Harkiss GD
Clin Exp Immunol; 1981 Feb; 43(2):231-9. PubMed ID: 6974064
[TBL] [Abstract][Full Text] [Related]
37. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
[TBL] [Abstract][Full Text] [Related]
38. IgG2 containing IgM-IgG immune complexes predominate in normal human plasma, but not in plasma of patients with warm autoimmune haemolytic anaemia.
Stahl D; Sibrowski W
Eur J Haematol; 2006 Sep; 77(3):191-202. PubMed ID: 16923106
[TBL] [Abstract][Full Text] [Related]
39. The clearance of tetanus toxoid/anti-tetanus toxoid immune complexes from the circulation of humans. Complement- and erythrocyte complement receptor 1-dependent mechanisms.
Schifferli JA; Ng YC; Estreicher J; Walport MJ
J Immunol; 1988 Feb; 140(3):899-904. PubMed ID: 2963069
[TBL] [Abstract][Full Text] [Related]
40. Concerted clearance of immune complexes bound to the human erythrocyte complement receptor: development of a heterologous mouse model.
Henderson AL; Lindorfer MA; Kennedy AD; Foley PL; Taylor RP
J Immunol Methods; 2002 Dec; 270(2):183-97. PubMed ID: 12379324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
